Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer
Clinical trial NCT06671262 · RECRUITING
Trial details
- NCT number
- NCT06671262
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-26
- Primary completion
- 2026-11-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.